Analyst Activity – Leerink Swann Raises Its Price Target On ASND – Ascendis Pharma (NASDAQ:ASND) to $64.00

ME Staff
-
0

Analyst Ratings For ASND – Ascendis Pharma (NASDAQ:ASND)

Today, Leerink Swann raised its price target on ASND – Ascendis Pharma (NASDAQ:ASND) to $64.00 per share.

Some recent analyst ratings include

  • 2/26/2018-Wedbush Reiterated Rating of Outperform.
  • 1/19/2018-HC Wainwright Reiterated Rating of Buy.
  • 9/22/2017-Wells Fargo Reiterated Rating of Buy.


    Recent Trading Activity for ASND – Ascendis Pharma (NASDAQ:ASND)
    Shares of ASND – Ascendis Pharma closed the previous trading session at with 65.72000122070312 shares trading hands.